Nikhil Lalwani Salary and Compensation - ANI PHARMACEUTICALS INC CEO Salary 2025

In fiscal year 2025, Nikhil Lalwani, President and Chief Executive Officer of ANI PHARMACEUTICALS INC (ANIP), received total compensation of $10.3 million.

Nikhil Lalwani's compensation breakdown includes: base salary of $837K, stock awards valued at $7.8 million, non-equity incentive compensation of $1.6 million, and other compensation of $20K.

Compared to fiscal year 2024, Nikhil Lalwani's total compensation increased 16% from $8.9 million to $10.3 million.

ANI PHARMACEUTICALS INC (ANIP) Executive Pay 2025

ANI PHARMACEUTICALS INC's top 5 named executive officers received combined total compensation of $21.6 million in fiscal year 2025.

The named executive officers disclosed in ANI PHARMACEUTICALS INC's 2025 proxy statement are:Nikhil Lalwani (President and Chief Executive Officer) with total compensation of $10.3 million, Christopher K. Mutz (Senior Vice President Head of Rare Disease) with total compensation of $3.4 million, Stephen P. Carey (Senior Vice President Finance and Chief Financial Officer) with total compensation of $3.3 million, Meredith W. Cook (Senior Vice President General Counsel and Corporate Secretary) with total compensation of $2.3 million, and Ori Gutwerg (Senior Vice President Generics) with total compensation of $2.3 million.